Teva has been doing some major global restructuring since Kare Schultz came to the helm of the embattled, Israeli drugmaker. So deep were the cuts in Israel that a general strike briefly shut down most of the country, including its airport and banking services, in December 2017.
Undeterred, Shultz has pushed ahead and expanded those cuts to the North American market, shedding 200 workers from its North American headquarters in Pennsylvania at the beginning of the year.